Stage 5 kidney failure means your kidneys are functioning at less than 15 percent of their normal capacity, a level too low to keep you alive without some form of treatment. At this point, waste products and excess fluid build up in the blood faster than your kidneys can clear them, and without dialysis or a transplant, the condition is fatal. But a diagnosis of stage 5 does not mean life stops. It means life changes, and understanding what those changes look like gives you real power over the decisions ahead.
What “Stage 5” Actually Refers To
Chronic kidney disease is graded on a five-stage scale based on how well your kidneys filter blood, measured by a number called the estimated glomerular filtration rate, or eGFR. A healthy eGFR sits above 90. Stage 5 begins when that number drops below 15, meaning the kidneys are filtering only a small fraction of what they should. At this level, the kidneys can no longer maintain the chemical balance your body depends on. Sodium, potassium, phosphorus, and acid all drift out of their normal ranges, and toxic waste products that healthy kidneys flush into the urine start accumulating in the bloodstream.
You may also hear stage 5 called “end-stage renal disease” or ESRD. The name sounds grim, but it is a clinical classification, not a death sentence. It signals that kidney replacement therapy, either dialysis or transplantation, is now medically necessary for survival. Some people reach stage 5 rapidly after an acute event, but far more arrive gradually over years, progressing through stages 3 and 4 with symptoms that creep in so slowly they become the new normal.
How You Got Here
Two conditions account for the majority of stage 5 cases worldwide: diabetes and high blood pressure. Diabetic nephropathy, the specific kidney damage that long-standing diabetes causes, is one of the leading paths to end-stage renal disease.1PubMed Central. The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management Hypertension runs a close second, and in many populations these two causes together account for the bulk of advanced kidney failure.2PubMed. Hypertension and diabetes remain the main causes of chronic renal failure in Fars Province, Iran 2013 Other causes include autoimmune diseases like lupus, inherited conditions like polycystic kidney disease, chronic urinary tract obstructions, and recurrent kidney infections. Sometimes the cause is never pinpointed because the kidneys are already too scarred by the time a biopsy is performed.
Knowing the underlying cause matters because it shapes the rest of your care. If diabetes drove the kidney damage, tight blood sugar control remains important even after you start dialysis; uncontrolled glucose worsens cardiovascular risk and can complicate vascular access for treatment.3European Journal of Clinical Pharmacy. Diabetic Nephropathy: Spectrum and Clinical Outcomes Impact of Glycemic Control on Progression to ESRD If hypertension is the culprit, blood pressure management stays central. The original disease does not vanish just because the kidneys have reached their lowest stage.
What Is Happening Inside Your Body
Healthy kidneys do far more than make urine. They regulate fluid volume, keep electrolytes in balance, activate vitamin D, help produce red blood cells, and clear a huge range of waste molecules from the blood. When function drops below 15 percent, that entire system falters. The clinical picture that results is called uremia, a term that refers to the constellation of symptoms caused by the buildup of toxic waste products in the blood.4PubMed Central. A Historical Perspective on Uremia and Uremic Toxins
Many of these waste molecules are protein-bound, meaning they cling to proteins in your blood and resist removal even by dialysis.5PubMed Central. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia Two of the most studied are indoxyl sulfate and p-cresyl sulfate, which promote calcium deposits in artery walls, stiffen blood vessels, and contribute to heart problems.6PubMed Central. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate This is one reason why cardiovascular disease, not kidney failure itself, is the leading cause of death among people on dialysis.
Acid-base balance also shifts. As kidney function falls, the organs lose their ability to excrete the daily acid load generated by normal metabolism, and a condition called metabolic acidosis develops. The risk climbs steeply once eGFR drops below about 40 and becomes nearly universal by stage 5.7American Journal of Kidney Diseases. Acid-Base Disorders in Chronic Kidney Disease: Core Curriculum 2019 Uncorrected acidosis accelerates muscle wasting, weakens bones, and can worsen kidney decline even further.
Why Heart Disease Becomes Your Biggest Risk
The relationship between failing kidneys and the cardiovascular system is so tight that kidney specialists treat heart health as inseparable from kidney care. Vascular calcification, the deposit of calcium-phosphate crystals inside artery walls, is one of the major drivers of heart-related illness and death at this stage.8PubMed Central. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall The process is fueled by high phosphorus levels, uremic toxins, chronic inflammation, and oxidative stress.
When the walls of large arteries stiffen from calcification, systolic blood pressure rises and diastolic pressure drops. The heart has to work harder against that stiffness, and coronary blood flow during the resting phase of each heartbeat is reduced. Over time, the heart muscle thickens and remodels, increasing the risk of heart attack and heart failure.9PubMed Central. Vascular Calcification in End-Stage Renal Disease This is why phosphorus-lowering medications, dietary phosphorus restriction, and careful blood pressure management are so heavily emphasized once you reach stage 5.
Treatment Options and What Each One Demands
There is no single correct treatment path for stage 5 kidney failure. The choice depends on your overall health, your personal priorities, the availability of a donor kidney, and what trade-offs you’re willing to accept in daily life.
Hemodialysis
Hemodialysis uses a machine to pump your blood through an external filter that removes waste and excess fluid. Most people on conventional hemodialysis go to a clinic three times a week for sessions lasting about four hours each. Some do it at home, which allows more flexibility and sometimes more frequent sessions. The treatment requires a long-term vascular access point, usually an arteriovenous fistula created surgically in the arm, though grafts and central venous catheters are also used.10PubMed Central. Overview of hemodialysis access and assessment
Access-related complications are among the most common issues in hemodialysis. Blood clots, narrowing of central veins, and aneurysms at the fistula site all occur, and diabetes and smoking lower the success rates of certain access types.11Journal of Surgery and Trauma. Comparing the outcomes of proximal radial artery arteriovenous fistula and brachio-cephalic arteriovenous fistula for hemodialysis vascular access Planning the access well in advance of when you need it, ideally months before dialysis starts, reduces emergency catheter placements and the infections that come with them.
Peritoneal Dialysis
Peritoneal dialysis uses the lining of your own abdominal cavity as a natural filter. A sterile fluid is infused through a permanently placed catheter in the abdomen, sits there while waste and fluid pass into it from the blood vessels lining the cavity, and is then drained out. Automated peritoneal dialysis does this exchange overnight using a machine, freeing up daytime hours. In studies of children, switching from manual to automated peritoneal dialysis lowered rates of infection, improved fluid removal, and reduced hospital stays.12PubMed. How automated peritoneal dialysis is applied and maintained in Japan Many adults find the independence of home-based peritoneal dialysis appealing, though the daily discipline of sterile technique and fluid management is not trivial.
Kidney Transplantation
A successful transplant is generally the closest thing to restoring normal kidney function. It frees you from dialysis and, for many people, allows a return to something resembling pre-disease daily life. A large retrospective study of nearly 1,850 transplant recipients found a mean post-transplant survival time of about 12 years, with receiving a kidney from a living donor roughly halving the risk of death compared with a deceased donor kidney.13PubMed Central. Life expectancy after kidney transplantation in a population-based retrospective cohort Age over 65, diabetes, heart failure, and smoking all independently increased the risk of dying after transplant, while higher pre-transplant hemoglobin levels were protective.
The trade-off is lifelong immunosuppressive medication, which prevents rejection but raises susceptibility to infections and certain cancers. Not everyone is a candidate for transplant: severe heart disease, active infection, or other serious conditions can disqualify you. And even those who are candidates face waiting lists that can stretch years for a deceased-donor kidney, making a living donor, when available, a far faster route.
Conservative Management Without Dialysis
For some people, particularly older adults with significant additional health problems, forgoing dialysis entirely and choosing conservative, symptom-focused care is a legitimate option. A systematic review of studies on this approach found that median survival without dialysis ranged from about 6 to 23 months, and that evidence was mixed on whether dialysis truly extended life in elderly patients compared with conservative care.14PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review Research has found that patients managed conservatively report symptom experiences and quality of life roughly comparable to those on dialysis, which challenges the assumption that dialysis always equals a better life.15PubMed. Quality of Life of Patients with Advanced Chronic Kidney Disease Receiving Conservative Care without Dialysis
Conservative management is not the same as doing nothing. It involves active medication management, dietary guidance, and palliative care to control symptoms like pain, nausea, and breathlessness. It should be discussed honestly as one option during treatment planning, especially for those who value comfort and time at home over the rigors of dialysis schedules.
The Symptom Burden You Should Expect
Stage 5 kidney failure is not a quiet disease. Symptoms are wide-ranging and often overlap, making daily life genuinely difficult even when treatment is going well.
Fatigue is the most common complaint. Roughly 70 percent of people with chronic kidney disease report fatigue, and up to a quarter describe it as severe.16PubMed Central. Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment This is not ordinary tiredness. It is a deep, persistent exhaustion that does not resolve with sleep and that correlates with higher rates of hospitalization and death. The causes are layered: anemia from reduced red blood cell production, toxin accumulation, poor sleep, muscle wasting, depression, and the physical stress of dialysis itself all contribute.
Sleep problems and restless legs syndrome are also very common among people on dialysis, as is uremic pruritus, an intense, maddening itch that has no visible rash and resists ordinary treatments.17PubMed Central. Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients These symptoms often go underreported because patients assume nothing can be done, or because clinic visits focus on lab numbers rather than how you actually feel. If you are experiencing them, raising them explicitly with your care team is important. Treatments exist, even if none of them are perfect.
Effects on Your Brain and Mood
The uremic toxins that accumulate in stage 5 do not stop at the blood vessels. There is growing evidence that they cross the blood-brain barrier and directly damage brain cells.18PubMed. Uremic toxins and the brain in chronic kidney disease The resulting condition, uremic encephalopathy, can range from subtle concentration problems and memory lapses to confusion, difficulty with planning and decision-making, and in severe cases, seizures or altered consciousness.19PubMed. Uremic encephalopathy Dialysis improves many of these symptoms by lowering toxin levels, but protein-bound toxins are not completely cleared, and some degree of cognitive impairment can persist.
Depression and fatigue are closely linked in this population. Multiple studies of people on hemodialysis have found a consistent association between the two, and the relationship holds even after accounting for other factors like age and additional health conditions.20PubMed. The Relationship Between Fatigue and Depression in Adults With End-Stage Renal Disease on Chronic In-Hospital Hemodialysis: A Scoping Review Depression in kidney failure is underdiagnosed and undertreated, partly because its symptoms overlap with uremia itself: fatigue, poor appetite, sleep disruption, and difficulty concentrating all belong to both. Screening for depression should be routine, and treatment can make a meaningful difference in how you experience daily life, even if the kidney disease itself cannot be reversed.
Medication Adjustments at Stage 5
One of the less visible but genuinely dangerous complications of stage 5 is the way it changes how your body handles medications. About 40 percent of commonly used drugs require dose adjustments when kidney function is reduced, and at stage 5, a typical patient is taking an average of six medications that need their doses lowered because the kidneys can no longer clear them at a normal rate.21PubMed Central. Polypharmacy and Dose Adjustment in Chronic Kidney Disease: A Cross-Sectional Study Pain relievers, antibiotics, blood pressure medications, and diabetes drugs are all common offenders. Without proper adjustment, drugs accumulate to toxic levels, causing side effects that can be mistaken for worsening kidney disease rather than recognized as a fixable medication problem.
If you are managing multiple conditions alongside kidney failure, as most people at this stage are, every new prescription and every over-the-counter medication you consider should be checked against your current kidney function. Your pharmacist can be a valuable ally here, sometimes catching conflicts that a busy clinic appointment misses.
The Financial and Daily-Life Toll
Stage 5 kidney failure reshapes your finances and work life in ways that extend well beyond medical bills. A multinational survey found that the financial and productivity burdens of chronic kidney disease are significant for both patients and their caregivers, with the heaviest impacts falling on those receiving dialysis.22PubMed Central. PaCE CKD: A Multinational Survey of Financial Burden and Work Productivity in Patients with Chronic Kidney Disease and Caregivers Many patients reduce their working hours or stop working entirely, and the ripple effect hits the household: partners often scale back their own jobs to provide care, compounding the income loss.
Spousal caregivers describe the strain in qualitative interviews as pervasive, affecting their ability to maintain employment and their overall financial stability, driven by the combination of lost income and ongoing healthcare costs.23American Journal of Kidney Diseases. Contributing and Alleviating Determinants of Burden in Spousal Caregivers of Patients With Kidney Failure: A Qualitative Interview Study Social work support, early financial counseling, and connecting with patient advocacy organizations can mitigate some of this, but the reality is that advanced kidney disease is expensive to live with in every sense of the word.
Having the Harder Conversations
Advance care planning in stage 5 kidney disease goes beyond filling out a form about resuscitation preferences. It includes decisions about whether to start dialysis, whether to continue it if quality of life deteriorates, what your priorities are if your health declines further, and what ethical, psychosocial, and even spiritual concerns matter to you.24PubMed Central. Shared Decision-Making, Advance Care Planning for Chronic Kidney Disease Patients These conversations are best had early, when you are well enough to participate fully, rather than in a crisis when decisions get made quickly and sometimes poorly.
A good care team will initiate these discussions rather than avoid them. If yours has not, you can bring it up yourself. Ask explicitly about what each treatment path looks like in practice, what the expected trajectory is, and what stopping treatment would mean. None of these questions imply giving up. They are the opposite: they put the decisions in your hands while you are in the best position to make them.
Research That Could Change the Landscape
The current options for stage 5, dialysis or transplant, have been the mainstays for decades. But several research directions could eventually expand the menu. Gene-edited pig kidneys are being investigated as a potential alternative source for transplantation, which could dramatically reduce the organ shortage that leaves hundreds of thousands of patients waiting worldwide.25PubMed Central. Future Therapy for End-Stage Kidney Failure: Gene-Edited Pig Kidney Xenotransplantation Early human cases have generated significant media attention, though the long-term viability and safety of these transplants remain unproven.
Separately, work on a wearable bioartificial kidney aims to combine continuous blood filtration with living kidney cells grown on hollow-fiber membranes, potentially restoring some of the biological functions that conventional dialysis cannot replicate.26PubMed. Research into the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells A device like this could free patients from the clinic-bound schedule of hemodialysis and improve clearance of the protein-bound toxins that current machines handle poorly. Neither of these innovations is available as standard treatment today, but both represent genuinely new approaches rather than incremental improvements on existing technology.